WWW.NATURE.COM/NATURE
Editorial contacts: While the best contacts for stories will always be the authors themselves, in some cases the Nature editor who handled the paper will be available for comment if an author is unobtainable. Editors are contactable via Ruth Francis on +44 20 7843 4562. Feel free to get in touch with Nature's press contacts in London, Washington and Tokyo (as listed at the end of this release) with any general editorial inquiry.
Warning: This document, and the Nature papers to which it refers, may contain information that is price sensitive (as legally defined, for example, in the UK Criminal Justice Act 1993 Part V) with respect to publicly quoted companies. Anyone dealing in securities using information contained in this document or in advanced copies of Nature’s content may be guilty of insider trading under the US Securities Exchange Act of 1934.
The Nature journals press site is at http://press.nature.com
PICTURES: While we are happy for images from Nature to be reproduced for the purposes of contemporaneous news reporting, you must also seek permission from the copyright holder (if named) or author of the research paper in question (if not).
HYPE: We take great care not to hype the papers mentioned on our press releases, but are sometimes accused of doing so. If you ever consider that a story has been hyped, please do not hesitate to contact us at [email protected], citing the specific example.
PLEASE CITE NATURE AND OUR WEBSITE www.nature.com/nature AS THE SOURCE OF THE FOLLOWING ITEMS. IF PUBLISHING ONLINE, PLEASE CARRY A HYPERLINK TO http://www.nature.com/nature
Genetics: Genetic variants associated with schizophrenia *PRESS BRIEFING*
[1] DOI: 10.1038/nature08185
[2] DOI: 10.1038/nature08186
[3] DOI: 10.1038/nature08192
Three papers in Nature this week provide new insights into genetic variation and schizophrenia risk. Using combined data from three large cohorts, the papers jointly reveal significant associations to individual loci that implicate immunity, cognition and brain development. Additionally, one of the papers provides genetic evidence for a substantial polygenic component to risk of schizophrenia that also contributes to risk of bipolar disorder.
Pamela Sklar and the International Schizophrenia Consortium show that common genetic variation underlies risk of schizophrenia. Their study identifies common variants within the major histocompatibility complex (MHC) locus, and provides molecular genetic evidence for a substantial polygenic component to risk of schizophrenia that involved thousands of common alleles of very small effect. These alleles of small effect also contribute to risk of bipolar disorder.
Kari Stefansson and colleagues present a genome-wide association of single nucleotide polymorphisms (SNPs) and reveal significant associations to individual loci that implicate immunity, brain development, memory and cognition in predisposition to schizophrenia.
Pablo Gejmans and the Molecular Genetics of Schizophrenia use a case-control study design to show an association between the MHC genomic locus and schizophrenia. Their results suggest a possible involvement of chromatin proteins in this disorder.
Together, by using meta-analysis of almost 10,000 cases and 20,000 controls, these three studies indicate that although common genetic variation that underlies risk to schizophrenia can be identified, there are probably few or no single common loci with large effects.
CONTACT
Pamela Sklar (Massachusetts General Hospital, Boston, MA, USA) Author paper [1]
Tel: +1 617 726 0475; E-mail: [email protected]
Kari Stefansson (DeCODE Genetics, Regykjavik, Iceland)
This author can be contacted through:
Edward Farmer (Media Relations, DeCODE Genetics, Regykjavik, Iceland) Author paper [2]
Tel: +44 779 601 0107; E-mail: [email protected]
Pablo Gejman (NorthShore University HealthSystem Research Institute, Evanston, IL, USA) Author paper [3]
Tel: +1 224 364 7550; E-mail: [email protected]
PRESS CONTACTS…
From North America and Canada
Neda Afsarmanesh, Nature New York
Tel: +1 212 726 9231; E-mail: [email protected]
Katie McGoldrick, Nature Washington
Tel: +1 202 737 2355; E-mail: [email protected]
From Japan, Korea, China, Singapore and Taiwan
Mika Nakano, Nature Tokyo
Tel: +81 3 3267 8751; E-mail: [email protected]
From the UK/Europe/other countries not listed above
Jen Middleton, Nature London
Tel: +44 20 7843 4502; E-mail [email protected]
About Nature Publishing Group (NPG):
Nature Publishing Group is a division of Macmillan Publishers Ltd, dedicated to serving the academic and professional scientific and medical communities. NPG’s flagship title, Nature, was first published in 1869. Other publications include Nature research journals, Nature Reviews, Nature Clinical Practice and a range of prestigious academic journals including society-owned publications. NPG also provides news content through Nature News. Scientific career information and free job postings are offered on Naturejobs.
NPG is a global company with principal offices in London, New York and Tokyo and offices in Basingstoke, Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Melbourne, Munich, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.
